Clinical Trial Update: Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of XAV-19 in patients with COVID-19–related moderate pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• XAV-19

Snippet

Sponsor: Nantes University Hospital | Conditions: SARS Virus | Phase 2 | Status: COMPLETED